1. European Menopause and Andropause Society (EMAS) and International Gynecologic Cancer Society (IGCS) position statement on managing the menopause after gynecological cancer: focus on menopausal symptoms and osteoporosis. Issue 4 (11th February 2020) Authors: Rees, Margaret; Angioli, Roberto; Coleman, Robert L; Glasspool, Rosalind M; Plotti, Francesco; Simoncini, Tommaso; Terranova, Corrado Journal: International journal of gynecological cancer Issue: Volume 30:Issue 4(2020) Page Start: 428 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. European Network of Gynaecological Oncological Trial Groups' requirements for trials between academic groups and industry partners ‐ a new Model D for drug and medical device development. Issue 6 (June 2020) Authors: Concin, Nicole; Ray‐Coquard, Isabelle; Glasspool, Rosalind M; Braicu, Elena; Farrelly, Laura; Votan, Benedicte; Mirza, Mansoor Raza; Martin, Antonio Gonzalez; Vergote, Ignace; Pignata, Sandro Journal: International journal of gynecological cancer Issue: Volume 30:Issue 6(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. European Network of Gynaecological Oncological Trial Groups' requirements for trials between academic groups and industry partners – a new Model D for drug and medical device development. Issue 6 (12th May 2020) Authors: Concin, Nicole; Ray-Coquard, Isabelle; Glasspool, Rosalind M; Braicu, Elena; Farrelly, Laura; Votan, Benedicte; Mirza, Mansoor Raza; Gonzalez Martin, Antonio; Vergote, Ignace; Pignata, Sandro Journal: International journal of gynecological cancer Issue: Volume 30:Issue 6(2020) Page Start: 730 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Objective responses to first-line neoadjuvant carboplatin–paclitaxel regimens for ovarian, fallopian tube, or primary peritoneal carcinoma (ICON8): post-hoc exploratory analysis of a randomised, phase 3 trial. Issue 2 (February 2021) Authors: Morgan, Robert D; McNeish, Iain A; Cook, Adrian D; James, Elizabeth C; Lord, Rosemary; Dark, Graham; Glasspool, Rosalind M; Krell, Jonathan; Parkinson, Christine; Poole, Christopher J; Hall, Marcia; Gallardo-Rincón, Dolores; Lockley, Michelle; Essapen, Sharadah; Summers, Jeff; Anand, Anjana; Zach... Journal: Lancet oncology Issue: Volume 22:Issue 2(2021) Page Start: 277 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Real world outcomes in platinum sensitive relapsed ovarian, fallopian tube, or peritoneal cancer treated in routine clinical practice in the United Kingdom prior to poly-ADP ribose polymerase inhibitors. Issue 7 (21st April 2020) Authors: Lord, Rosemary; Rauniyar, Jyoti; Morris, Tamsin; Condon, Orlaith; Jones, Rachel; Miller, Rowan; Hall, Marcia; Lofts, Fiona; Glasspool, Rosalind M; Hudson, Emma Journal: International journal of gynecological cancer Issue: Volume 30:Issue 7(2020) Page Start: 1026 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Real world outcomes in platinum sensitive relapsed ovarian, fallopian tube, or peritoneal cancer treated in routine clinical practice in the United Kingdom prior to poly‐ADP ribose polymerase inhibitors. Issue 7 (July 2020) Authors: Lord, Rosemary; Rauniyar, Jyoti; Morris, Tamsin; Condon, Orlaith; Jones, Rachel; Miller, Rowan; Hall, Marcia; Lofts, Fiona; Glasspool, Rosalind M; Hudson, Emma Journal: International journal of gynecological cancer Issue: Volume 30:Issue 7(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal cancer treatment (ICON8): overall survival results from an open-label, randomised, controlled, phase 3 trial. Issue 7 (July 2022) Authors: Clamp, Andrew R; James, Elizabeth C; McNeish, Iain A; Dean, Andrew; Kim, Jae-Won; O'Donnell, Dearbhaile M; Gallardo-Rincon, Dolores; Blagden, Sarah; Brenton, James; Perren, Tim J; Sundar, Sudha; Lord, Rosemary; Dark, Graham; Hall, Marcia; Banerjee, Susana; Glasspool, Rosalind M; Hanna, C Louise; ... Journal: Lancet oncology Issue: Volume 23:Issue 7(2022) Page Start: 919 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal carcinoma treatment (ICON8): primary progression free survival analysis results from a GCIG phase 3 randomised controlled trial. Issue 10214 (7th December 2019) Authors: Clamp, Andrew R; James, Elizabeth C; McNeish, Iain A; Dean, Andrew; Kim, Jae-Weon; O'Donnell, Dearbhaile M; Hook, Jane; Coyle, Christopher; Blagden, Sarah; Brenton, James D; Naik, Raj; Perren, Tim; Sundar, Sudha; Cook, Adrian D; Gopalakrishnan, Gosala S; Gabra, Hani; Lord, Rosemary; Dark, Graham;... Journal: Lancet Issue: Volume 394:Issue 10214(2019) Page Start: 2084 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗